The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
Open accessAbstract
The ability of recombinant adeno-associated virus (AAV) to transduce cells with a marker gene in vitro was found to be substantially increased by the presence of adenovirus. Transfection experiments with adenovirus genomic DNA suggest that this increase is not facilitated by adenovirus-mediated viral uptake but is instead dependent on adenovirus gene expression. Using various adenovirus mutants, we were able to map this function to early-region E4 open reading frame 6. Plasmid expression of open reading frame 6 protein in cells infected with recombinant AAV increased transduction between 100- and 1,000-fold. The increase in transduction was not dependent on the recombinant AAV gene cassette but instead appeared to involve an immediate early step of the AAV life cycle. Chemical and physical agents that have been shown to induce helper-free replication of wild-type AAV were also able to stimulate recombinant AAV transduction, suggesting that the phenomenon might affect AAV DNA replication. Further experiments showed that viral uncoating was not affected and that the rate-limiting step involved synthesis of a second strand on the single-stranded genomic AAV DNA. These data suggest that the adenovirus E4 region, as well as chemical and physical agents, can play an essential role in an immediate-early step of the AAV life cycle, specifically in second-strand synthesis, and have important implications for the use of AAV vectors in gene therapy protocols.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second strand synthesis after capsid uncoating in nucleus is long-recognized as the rate-limiting step of rAAV transduction (89); an improvement in such efficacy could allow rAAV administration at lower dose.”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [89]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L. R., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,116
(1952) · Cancer Research · Cited by 987
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Self-citationSite-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Jones, N. C., & Shenk, T. E. (1979) · Cell · doi:10.1016/0092-8674(79)90275-7 · Cited by 784
Self-citationTargeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Self-citationSamulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Self-citation
Cited by
Sorted by citations
Items 301–400 of 758
Meyers, C., Alam, S., Mane, M., & Hermonat, P. L. (2001) · Virology · doi:10.1006/viro.2001.0968 · Cited by 46
A fluorescence video-endoscopy technique for detection of gene transfer and expression
Flotte, T. R., Beck, S., Chesnut, K. A., Potter, M., Poirier, A., & Zolotukhin, S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300579 · Cited by 46
Gene therapy: Recombinant adeno-associated virus vectors
Smith-Arica, J. R., & Bartlett, J. S. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0009-x · Cited by 45
Structural and cellular biology of adeno-associated virus attachment and entry
Zengel, J. R., & Carette, J. E. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.01.002 · Cited by 47
Sun, X., Lü, Y., Bish, L. T., Calcedo, R., Wilson, J. M., & Gao, G. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.214 · Cited by 42
Freundlieb, S., Schirra‐Müller, C., & Bujard, H. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199901/02)1:1 · Cited by 262
Li, Z., Chen, L., Li, Y., Qing, K., Weigel-Kelley, K. A., Chan, R. J., Yöder, M. C., & Srivastava, A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.018 · Cited by 44
Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors
Braun‐Falco, M., Doenecke, A., Smola, H., & Hallek, M. J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300815 · Cited by 45
Structural and functional heterogeneity of integrated recombinant AAV genomes
Duan, D., Fisher, K. J., Burda, J. F., & Engelhardt, J. F. (1997) · Virus Research · doi:10.1016/s0168-1702(96)01425-6 · Cited by 45
Spampanato, C., Leonibus, E. D., Dama, P., Gargiulo, A., Fraldi, A., Sorrentino, N. C., Russo, F., Nusco, E., Auricchio, A., Surace, E. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.299 · Cited by 47
Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors
Rehman, K. K., Wang, Z., Bottino, R., Balamurugan, A. N., Trucco, M., Li, J., Xiao, X., & Robbins, P. D. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302530 · Cited by 44
Direct Gene Therapy for Repair of the Spinal Cord
Blits, B., & Bunge, M. B. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.508 · Cited by 44
Genetic interventions for vein bypass graft disease: A review
Conte, M. S., Mann, M. J., Simosa, H. F., Rhynhart, K. K., & Mulligan, R. C. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.129112 · Cited by 44
Zhong, L., Li, W., Yang, Z., Chen, L., Li, Y., Qing, K., Weigel-Kelley, K. A., Yöder, M. C., Shou, W., & Srivastava, A. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302283 · Cited by 42
Hirsch, M. L., Green, L., Porteus, M. H., & Samulski, R. J. (2010) · Gene Therapy · doi:10.1038/gt.2010.65 · Cited by 45
Self-citationIn vivo gene delivery to articular chondrocytes mediated by an adeno‐associated virus vector
Ulrich‐Vinther, M., Duch, M., Søballé, K., O’Keefe, R. J., Schwarz, E., & Pedersen, F. S. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.003 · Cited by 42
Kanazawa, T., Mizukami, H., Okada, T., Hanazono, Y., Kume, A., Nishino, H., Takeuchi, K., Kitamura, K., Ichimura, K., & OZAWA, K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301837 · Cited by 42
Peng, D., Qian, C., Sun, Y., Barajas, M., & Prìeto, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80102-6 · Cited by 42
Mitchell, A. M., Li, C., & Samulski, R. J. (2013) · Journal of Virology · doi:10.1128/jvi.03443-12 · Cited by 41
Self-citationLi, Z., Zhou, X., Li, Y., Qing, K., Xiao, X., Samulski, R. J., & Srivastava, A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300376 · Cited by 43
Self-citationEnhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells.
Burg, M. A., Jensen-Pergakes, K., Gonzalez, A. M., Ravey, P., Baird, A., & Larocca, D. (2002) · PubMed · Cited by 41
Bertran, J., Miller, J. L., Yang, Y., Fenimore-Justman, A., Rueda, F., Vanin, E. F., & Nienhuis, A. W. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6759-6766.1996 · Cited by 41
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ail, D., Malki, H., Zin, E. A., & Dalkara, D. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s383453 · Cited by 40
Sipo, I., Fechner, H., Pinkert, S., Suckau, L., Wang, X., Weger, S., & Poller, W. C. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302987 · Cited by 41
Strategies of Conditional Gene Expression in Myocardium
Heine, H. L., Leong, H. S., Rossi, F. M. V., McManus, B. M., & Podor, T. J. (2005) · Methods in molecular medicine · doi:10.1007/978-1-59259-879-3_8 · Cited by 40
Spatial and Temporal Organization of Adeno-Associated Virus DNA Replication in Live Cells
Fraefel, C., Bittermann, A. G., Büeler, H., Heid, I., Bächi, T., & Ackermann, M. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.389-398.2004 · Cited by 40
Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction
Mano, M., Ippodrino, R., Zentilin, L., Zacchigna, S., & Giacca, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503607112 · Cited by 39
Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?
Brown, N. J., Song, L., Rao, K. N., & Hirsch, M. L. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.038 · Cited by 42
Lin, A. Z., & Balazs, A. B. (2018) · Retrovirology · doi:10.1186/s12977-018-0449-7 · Cited by 41
Overview of Adeno-Associated Viral Vectors
Daly, T. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-650-9:157 · Cited by 39
Mitrani‐Rosenbaum, S., Yakovlev, L., Becker‐Cohen, M., Telem, M., Elbaz, M., Yanay, N., Yotvat, H., Shlomo, U. B., Harazi, A., Fellig, Y., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.03.013 · Cited by 39
Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication
Wang, Z., Deng, X., Zou, W., Engelhardt, J. F., Yan, Z., & Qiu, J. (2017) · Journal of Virology · doi:10.1128/jvi.00710-17 · Cited by 41
Ago, Y., Rintz, E., Musini, K. S., Ma, Z., & Tomatsu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021113 · Cited by 44
AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods
Palaschak, B., Herzog, R. W., & Markusic, D. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9139-6_20 · Cited by 37
Jayandharan, G. R., Li, Z., Sack, B. K., Rivers, A. E., Li, M., Li, B., Herzog, R. W., & Srivastava, A. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.100 · Cited by 38
Petersen‐Jones, S. M., Bartoe, J. T., Fischer, A. J., Scott, M. A., Boye, S. L., Chiodo, V. A., & Hauswirth, W. W. (2009) · PubMed · Cited by 38
Eslami, M. H., Gangadharan, S. P., Sui, X., Rhynhart, K. K., Snyder, R. O., & Conte, M. S. (2000) · Journal of Vascular Surgery · doi:10.1067/mva2000.106951 · Cited by 38
Luo, X., Hall, G., Li, S., Bird, A., Lavin, P., Winn, M. P., Kemper, A. R., Brown, T. T., & Koeberl, D. D. (2011) · Molecular Therapy · doi:10.1038/mt.2011.126 · Cited by 40
Collaco, R. F., Bevington, J. M., Bhrigu, V., Kalman‐Maltese, V., & Trempe, J. P. (2009) · Virology · doi:10.1016/j.virol.2009.06.005 · Cited by 40
Processing of adeno-associated virus RNA
Qiu, J. (2007) · Frontiers in bioscience · doi:10.2741/2912 · Cited by 37
Jayandharan, G. R., Zhong, L., Li, B., Kachniarz, B., & Srivastava, A. (2008) · Gene Therapy · doi:10.1038/gt.2008.89 · Cited by 37
Gene therapy: principles and applications to hematopoietic cells
Tendeloo, V. F. V., Broeckhoven, C. V., & Berneman, Z. N. (2001) · Leukemia · doi:10.1038/sj.leu.2402085 · Cited by 37
Ulrich‐Vinther, M., Maloney, M. D., Goater, J. J., Søballé, K., Goldring, M. B., O’Keefe, R. J., & Schwarz, E. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10433 · Cited by 37
Şanlıoğlu, S., & Engelhardt, J. F. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300967 · Cited by 37
Polyak, S., Mah, C. S., Porvasnik, S., Herlihy, J.-D. H., Campbell‐Thompson, M., Byrne, B. J., & Valentine, J. F. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9991-1 · Cited by 36
Regulation of gene expression in adeno-associated virus vectors in the brain
Haberman, R. P., & McCown, T. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00226-8 · Cited by 37
Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors
Montenegro-Miranda, P. S., Bloemendaal, L. T., Kunne, C., de Waart, D. R., & Bosma, P. J. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.222 · Cited by 35
McCarthy, H. O., Coulter, J. A., Robson, T., & Hirst, D. G. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.8.0007 · Cited by 34
Tutorial: design and execution of CRISPR in vivo screens
Braun, C. J., Adames, A. C., Saur, D., & Rad, R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00700-y · Cited by 38
Jiang, M.-H., Liu, Z., Xiang, Y., Ma, H., Liu, S.-L., Liu, Y.-X., & Zheng, D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-54 · Cited by 37
Cataldi, M. P., & McCarty, D. M. (2010) · Journal of Virology · doi:10.1128/jvi.00641-10 · Cited by 36
Gonçalves, M. A. F. V., Pau, M. G., de Vries, A. A. F., & Valerio, D. (2001) · Virology · doi:10.1006/viro.2001.1073 · Cited by 35
A cis-Acting Element That Directs Circular Adeno-Associated Virus Replication and Packaging
Musatov, S., Roberts, J., Pfaff, D., & Kaplitt, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12792-12802.2002 · Cited by 34
Srivastava, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.792 · Cited by 35
TOWARD CYSTIC FIBROSIS GENE THERAPY
Wagner, J. A., & Gardner, P. I. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.203 · Cited by 35
Viral vectors for gene delivery to the inner ear
Maguire, C. A., & Corey, D. P. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107927 · Cited by 33
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles
Rohr, U., Heyd, F., Neukirchen, J., Wulf, M.-A., Queitsch, I., Kroner‐Lux, G., Steidl, U. G., Fenk, R. R., Haas, R. R., & Kronenwett, R. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.03.006 · Cited by 34
Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?
Giacca, M. (2007) · PubMed Central · Cited by 34
Duong, T. T., Lim, J., Vasireddy, V., Papp, T., Nguyen, H., Leo, L., Pan, J., Zhou, S., Chen, H. I., Bennett, J., et al. (2019) · Stem Cells International · doi:10.1155/2019/7281912 · Cited by 33
Hendrie, P. C., Hirata, R. K., & Russell, D. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13136-13145.2003 · Cited by 33
Quantitative 3D Tracing of Gene-delivery Viral Vectors in Human Cells and Animal Tissues
Xiao, P.-J., Li, C., Neumann, A., & Samulski, R. J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.250 · Cited by 33
Self-citationDelivery of CRISPR/Cas9 system by AAV as vectors for gene therapy
Wang, Y., Jiang, H., Li, M., Xu, Z., Xu, H., Chen, Y., Chen, K., Zheng, W., Lin, W., Lin, Z., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148733 · Cited by 37
Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
de Backer, M. W. A., la Fleur, S. E., Brans, M. A. D., van Rozen, A. J., Luijendijk, M. C. M., Merkestein, M., Garner, K. M., van der Zwaal, E. M., & Adan, R. A. H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.169 · Cited by 33
Nayak, R., & Pintel, D. J. (2007) · Journal of Virology · doi:10.1128/jvi.01132-07 · Cited by 33
Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium.
Tsai, M., Chen, S., Chou, P.-I., Wen, L.-Y., Tsai, R. J.-F., & Tsao, Y. (2002) · PubMed · Cited by 33
Delayed Expression of Adeno-Associated Virus Vector DNA
Afione, S. A., Wang, J., Walsh, S. M., Guggino, W. B., & Flotte, T. R. (1999) · Intervirology · doi:10.1159/000024980 · Cited by 33
Su, W., Kang, J., Sopher, B. L., Gillespie, J., Aloi, M. S., Odom, G. L., Hopkins, S., Case, A., Wang, D. B., Chamberlain, J. S., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13081 · Cited by 37
Sapieha, P. S., Hauswirth, W. W., & Polo, A. D. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20803 · Cited by 32
Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease
Mühle, C., Neuner, A., Park, J., Pacho, F., Jiang, Q., Waddington, S. N., & Schneider, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302832 · Cited by 32
Mathews, L. C., Gray, J. T., Gallagher, M. R., & Snyder, R. O. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46068-5 · Cited by 32
Gene therapy for inherited retinal degeneration
Ali, R. R., Reichel, M. B., Hunt, D. M., & Bhattacharya, S. S. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.9.795 · Cited by 33
Maass, G., Bogedain, C., Scheer, U., Michl, D., Hörer, M., Braun‐Falco, M., Volkenandt, M., Schadendorf, D., Wendtner, C., Winnacker, E., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.7-1049 · Cited by 30
Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia
Markusic, D. M., & Herzog, R. W. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-009 · Cited by 31
Berraondo, P., Crettaz, J. S., Ochoa‐Callejero, L., Pañeda, A., Prìeto, J., Trocóniz, I. F., & González‐Aseguinolaza, G. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.601 · Cited by 31
Wheeler, M. D., Kono, H., Rusyn, I., Arteel, G. E., McCarty, D. M., Samulski, R. J., & Thurman, R. G. (2000) · Hepatology · doi:10.1053/jhep.2000.19339 · Cited by 31
Self-citationRecombinant adeno-associated Virus: Clinical Application and Development As a gene-therapy Vector
Xiao, P.-J., Lentz, T. B., & Samulski, R. J. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.63 · Cited by 31
Self-citationDíaz‐Lezama, N., Wu, Z., Adán‐Castro, E., Arnold, E., Vázquez‐Membrillo, M., Zamarripa, D. A., Ledesma-Colunga, M. G., Moreno-Carranza, B., de la Escalera, G. M., Colosi, P., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.135 · Cited by 29
Zhang, X., Chen, Z., Chen, Y., & Tong, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206317 · Cited by 30
Gene transfer into hematopoietic cells
Nienhuis, A. W., Bertran, J., Hargrove, P. W., Yang, Y., & Vanin, E. F. (1997) · Stem Cells · doi:10.1002/stem.5530150816 · Cited by 30
Santat, L. A., Paz, H., Wong, C., Li, L., Macer, J. A., Forman, S. J., Wong, K., & Chatterjee, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502902102 · Cited by 29
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
Ivacik, D., Ely, A., & Arbuthnot, P. B. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.705 · Cited by 29
Fakhiri, J., & Grimm, D. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.005 · Cited by 29
Feng, X. (2004) · Frontiers in bioscience · doi:10.2741/1323 · Cited by 29
Ren, C., Kumar, S., Shaw, D. R., & Ponnazhagan, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1047 · Cited by 30
Liu, D., Chang, J., Tsao, Y., Huang, C., Kuo, S.-W., & Chen, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20530 · Cited by 29
Recombinant adeno-associated virus vector design and gene expression in the mammalian brain
Paterna, J., & Büeler, H. (2002) · Methods · doi:10.1016/s1046-2023(02)00225-6 · Cited by 29
Strategies to improve safety profile of AAV vectors
Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1054069 · Cited by 32
In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313
Nyberg, W. A., Wang, C. H., Ark, J., Liu, C., Clouden, S., Qualls, A., Caryotakis, S. E., Wells, E., Simon, K. E., Garza, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.01.009 · Cited by 32
Lee, S. H., Yang, J. Y., Madrakhimov, S. B., Park, H. Y., Park, K., & Park, T. K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.11.008 · Cited by 28
Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription
Madigan, V. J., Yuziuk, J. A., Chiarella, A. M., Tyson, T. O., Meganck, R. M., Elmore, Z. C., Tse, L. V., Hathaway, N. A., & Asokan, A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007988 · Cited by 28
Srivastava, A. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10053 · Cited by 28
Grifman, M., Chen, N. N., Gao, G., Cathomen, T., Wilson, J. M., & Weitzman, M. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10010-10019.1999 · Cited by 28
Gene Transfer Approaches to the Lysosomal Storage Disorders
Barranger, J. A., Rice, E. O., & Swaney, W. P. (1999) · Neurochemical Research · doi:10.1023/a:1022548232735 · Cited by 28
AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
van der Laan, L. J. W., Wang, Y., Tilanus, H. W., Janssen, H. L. A., & Pan, Q. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.548799 · Cited by 29
Recombinant AAV-directed gene therapy for type I glycogen storage diseases
CHOU, J. Y., & Mansfield, B. C. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.578067 · Cited by 28
Raj, D., Davidoff, A. M., & Nathwani, A. C. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.48 · Cited by 28
Bell, P., Wang, L., Chen, S.-J., Yu, H., Zhu, Y., Nayal, M., He, Z., White, J., Lebel-Hagan, D., & Wilson, J. M. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.039 · Cited by 26
AAV Recombineering with Single Strand Oligonucleotides
Hirsch, M. L., Storici, F., Li, C., Choi, V. W., & Samulski, R. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007705 · Cited by 26
Self-citationPozzuto, T., von Kietzell, K., Bock, C. –., Schmidt‐Lucke, C., Poller, W. C., Zobel, T., Laßner, D., Zeichhardt, H., Weger, S., & Fechner, H. (2011) · Virology · doi:10.1016/j.virol.2010.12.019 · Cited by 27
The emerging role of viral vectors as vehicles for DMD gene editing
Maggio, I., Chen, X., & Gonçalves, M. A. F. V. (2016) · Genome Medicine · doi:10.1186/s13073-016-0316-x · Cited by 27
Metadata
- Authors
- Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Shenk, T
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1996-05
- Volume
- 70
- Issue
- 5
- Pages
- 3227-3234
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC190186
- OpenAlex
- W2165815741
- Cited by
- 761
- References
- 46
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 13 · 2021: 15 · 2020: 25 · 2019: 17 · 2018: 15 · 2017: 10 · 2016: 22 · 2015: 27 · 2014: 21 · 2013: 17 · 2012: 27
- FWCI
- 24.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk042701-06)
- National Heart, Lung, and Blood Institute (HL48327, P01HL051818, HL51818)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 42701)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Keywords
- recombinant adeno-associated virus vectors, viral uncoating, gene therapy vectors
- MeSH terms
- Dependovirus, Adenoviridae, beta-Galactosidase, Cell Line, DNA, Viral, Genetic Vectors, HeLa Cells, Humans, Kinetics, Plasmids, Recombinant Proteins, Recombination, Genetic, Transduction, Genetic, Transfection, Ultraviolet Rays, X-Rays, Gene Expression, Mutagenesis, Open Reading Frames
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review